About this document

Fimmu 15 1377137 by mosabjad91 is a document available to read on EtoBox.

This editorial discusses the urgent need for immunotherapeutics development against Hantaviruses, which pose a significant global health challenge with limited FDA-approved treatments. It highlights innovative research efforts focusing on vaccine and drug development, as well as advancements in diagnostic technologies, emphasizing the importance of interdisciplinary collaboration. The editorial calls for continued investment in research to enhance global health security and improve management of Hantavirus

Author

mosabjad91

Language

EN